Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
RXRX
RXRX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
RXRX News
Recursion Pharmaceuticals Faces Major Challenges Ahead
1d ago
Fool
Recursion Pharmaceuticals Leverages AI to Accelerate R&D
1d ago
NASDAQ.COM
PacBio Appoints New Board Member
5d ago
Globenewswire
PacBio Appoints New Board Member
5d ago
Newsfilter
PACBIO NAMES CHRIS GIBSON TO ITS BOARD OF DIRECTORS
5d ago
moomoo
Recursion Pharmaceuticals Q4 2025 Earnings Call Insights
Feb 25 2026
seekingalpha
Recursion Pharmaceuticals Q4 Earnings Exceed Expectations
Feb 25 2026
seekingalpha
Recursion Pharmaceuticals Stock Surges After Strong Earnings Report
Feb 25 2026
Benzinga
Totaligent Forms Joint Venture with GloMed for Biologics Distribution
Feb 25 2026
Newsfilter
Recursion Pharmaceuticals Q4 2025 Earnings Highlights
Feb 25 2026
seekingalpha
Recursion Pharmaceuticals Q4 Results Exceed Expectations, Shares Surge
Feb 25 2026
stocktwits
Recursion Achieves Clinical Validation of AI Operating System
Feb 25 2026
Newsfilter
ARK Invest's 2025 Performance Review Highlights Key Stocks
Feb 24 2026
Benzinga
Recursion Pharmaceuticals Set to Announce Q4 Earnings on February 25
Feb 24 2026
seekingalpha
Earnings Reports Week for Major Companies
Feb 23 2026
Benzinga
Analysis of Three Declining Growth Stocks
Feb 22 2026
Fool
Show More News
